Literature DB >> 25103613

Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR).

Abhishek Sharma1, Sunny Goel, Carl J Lavie, Armin Arbab-Zadeh, Debabrata Mukherjee, Jason Lazar.   

Abstract

Transcatheter aortic valve replacement (TAVR) has been emerged as a promising alternative for the management of patients with severe AS who otherwise are deemed inappropriate candidates for surgery. Post procedural thromboembolic events and risk of bleeding continue to be a significant challenge in managing patients who underwent TAVR. This article systematically reviews the evidence, current guidelines and upcoming studies investigating antithrombotic therapy before, during and after TAVR.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25103613     DOI： 10.1007/s11239-014-1118-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


  43 in total

1.  Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.

Authors:  Neil E Moat; Peter Ludman; Mark A de Belder; Ben Bridgewater; Andrew D Cunningham; Christopher P Young; Martyn Thomas; Jan Kovac; Tom Spyt; Philip A MacCarthy; Olaf Wendler; David Hildick-Smith; Simon W Davies; Uday Trivedi; Daniel J Blackman; Richard D Levy; Stephen J D Brecker; Andreas Baumbach; Tim Daniel; Huon Gray; Michael J Mullen
Journal:  J Am Coll Cardiol       Date:  2011-10-20       Impact factor: 24.094

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.

Authors:  Corrado Tamburino; Davide Capodanno; Angelo Ramondo; Anna Sonia Petronio; Federica Ettori; Gennaro Santoro; Silvio Klugmann; Francesco Bedogni; Francesco Maisano; Antonio Marzocchi; Arnaldo Poli; David Antoniucci; Massimo Napodano; Marco De Carlo; Claudia Fiorina; Gian Paolo Ussia
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

Review 4.  Access site bleeding after transcatheter aortic valve implantation.

Authors:  Abhishek Sharma; Armin Arbab-Zadeh; Divyanshu Dubey; Jacob Shani; Jason Lazar; Robert Frankel
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

5.  Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.

Authors:  Alexander Ghanem; Andreas Müller; Claas P Nähle; Justine Kocurek; Nikos Werner; Christoph Hammerstingl; Hans H Schild; Jörg O Schwab; Fritz Mellert; Rolf Fimmers; Georg Nickenig; Daniel Thomas
Journal:  J Am Coll Cardiol       Date:  2010-02-24       Impact factor: 24.094

6.  Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.

Authors:  Martyn Thomas; Gerhard Schymik; Thomas Walther; Dominique Himbert; Thierry Lefèvre; Hendrik Treede; Holger Eggebrecht; Paolo Rubino; Iassen Michev; Rüdiger Lange; William N Anderson; Olaf Wendler
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

7.  Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion.

Authors:  Barbara Steinlechner; Petra Zeidler; Eva Base; Beatrice Birkenberg; Hendrik Jan Ankersmit; Michael Spannagl; Peter Quehenberger; Michael Hiesmayr; Bernd Jilma
Journal:  Ann Thorac Surg       Date:  2011-03-24       Impact factor: 4.330

8.  One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation.

Authors:  Thomas Walther; Marie-Theres Kasimir; Mirko Doss; Gerhard Schuler; Paul Simon; Volker Schächinger; Friedrich W Mohr; Gerhard Wimmer-Greinecker
Journal:  Eur J Cardiothorac Surg       Date:  2010-07-15       Impact factor: 4.191

9.  High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Authors:  M Heras; J H Chesebro; V Fuster; W J Penny; D E Grill; K R Bailey; G K Danielson; T A Orszulak; J R Pluth; F J Puga
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

10.  Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year.

Authors:  D L Walters; A Sinhal; D Baron; S Pasupati; S Thambar; G Yong; N Jepson; R Bhindi; J Bennetts; R Larbalestier; A Clarke; P Brady; H Wolfenden; A James; A El Gamel; P Jansz; D P Chew
Journal:  Int J Cardiol       Date:  2013-11-16       Impact factor: 4.164
View more
  2 in total

Review 1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2014

Review 2.  Effects of single versus dual antiplatelet therapy on the adverse events after transcatheter aortic valve implantation: A meta-analysis.

Authors:  Shengqin Yu; Shuying Zhang; Changli Yao; Jihong Liu
Journal:  Clin Cardiol       Date:  2021-10-19       Impact factor: 2.882
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.